[go: up one dir, main page]

UA93672C2 - 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones - Google Patents

7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Info

Publication number
UA93672C2
UA93672C2 UAA200710571A UAA200710571A UA93672C2 UA 93672 C2 UA93672 C2 UA 93672C2 UA A200710571 A UAA200710571 A UA A200710571A UA A200710571 A UAA200710571 A UA A200710571A UA 93672 C2 UA93672 C2 UA 93672C2
Authority
UA
Ukraine
Prior art keywords
naphthyridones
amino alkylidenyl
quinolones
heterocyclic
heterocyclic quinolones
Prior art date
Application number
UAA200710571A
Other languages
English (en)
Inventor
Грант Юджин Б., III
Марк Дж. Масилаг
Стивен Девид Пейджет
Мишель Энн Вейднер-Уэллс
Сяокин Су
Сяодонг Су
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA93672C2 publication Critical patent/UA93672C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UAA200710571A 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones UA93672C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/084,987 US7732612B2 (en) 2004-09-09 2005-03-21 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Publications (1)

Publication Number Publication Date
UA93672C2 true UA93672C2 (en) 2011-03-10

Family

ID=36648281

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710571A UA93672C2 (en) 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Country Status (22)

Country Link
US (1) US7732612B2 (ru)
EP (1) EP1861401B1 (ru)
JP (1) JP4977684B2 (ru)
KR (1) KR101323665B1 (ru)
CN (1) CN101248070B (ru)
AR (1) AR053342A1 (ru)
AU (1) AU2006227984A1 (ru)
BR (1) BRPI0609426B8 (ru)
CA (1) CA2602140C (ru)
CR (1) CR9458A (ru)
DK (1) DK1861401T3 (ru)
EA (1) EA014554B1 (ru)
ES (1) ES2561834T3 (ru)
IL (1) IL186041A (ru)
MX (1) MX2007011774A (ru)
MY (1) MY147638A (ru)
NO (1) NO340833B1 (ru)
NZ (1) NZ561651A (ru)
TW (1) TWI444380B (ru)
UA (1) UA93672C2 (ru)
WO (1) WO2006101603A1 (ru)
ZA (1) ZA200708868B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7913302B2 (en) * 2004-05-02 2011-03-22 Markmonitor, Inc. Advanced responses to online fraud
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
DE602006013878D1 (de) 2005-12-22 2010-06-02 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
HRP20110558T1 (hr) * 2006-03-28 2011-09-30 Warner Chilcott Company Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline
US7456279B2 (en) * 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
ES2524457T3 (es) 2008-05-29 2014-12-09 Bluestar Silicones France Artículo que presenta propiedades antiincrustantes, y destinado a ser utilizado en aplicaciones acuáticas, en particular marinas
US9012634B2 (en) 2011-08-10 2015-04-21 Janssen R&D Ireland Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
KR101774044B1 (ko) 2011-09-30 2017-09-01 얀센 파마슈티카 엔.브이. 2-[(2e)-2-플루오로-2-(3-피페리디닐리덴)에틸]-1h-이소인돌-1,3(2h)-디온을 제조하기 위한 개선된 방법
EP2928892B1 (en) * 2012-12-04 2018-03-21 Mankind Pharma Ltd. An improved process for the preparation of moxifloxacin hydrochloride
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO871333L (no) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JPH07300472A (ja) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol 新規キノロンカルボン酸誘導体およびその製造方法
JPH06263754A (ja) 1993-03-12 1994-09-20 Hokuriku Seiyaku Co Ltd 7−アミノピロリジニルキノリン−3−カルボン酸誘導体
JP4669607B2 (ja) * 1997-09-15 2011-04-13 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン類、その組成物およびその使用
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) * 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
JP2007522093A (ja) * 2003-09-22 2007-08-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 7−アミノアルキリデニル−複素環式キノロンおよびナフチリドン

Also Published As

Publication number Publication date
US7732612B2 (en) 2010-06-08
BRPI0609426A2 (pt) 2010-04-06
CA2602140C (en) 2015-04-14
CA2602140A1 (en) 2006-09-28
TWI444380B (zh) 2014-07-11
US20060052359A1 (en) 2006-03-09
CN101248070A (zh) 2008-08-20
TW200700418A (en) 2007-01-01
BRPI0609426B1 (pt) 2020-09-24
JP4977684B2 (ja) 2012-07-18
IL186041A (en) 2016-05-31
CR9458A (es) 2008-09-09
EA014554B1 (ru) 2010-12-30
NZ561651A (en) 2011-09-30
BRPI0609426B8 (pt) 2021-05-25
KR20070113304A (ko) 2007-11-28
CN101248070B (zh) 2011-12-14
JP2008538110A (ja) 2008-10-09
MX2007011774A (es) 2008-03-10
AU2006227984A1 (en) 2006-09-28
AR053342A1 (es) 2007-05-02
DK1861401T3 (en) 2015-12-07
NO340833B1 (no) 2017-06-26
ES2561834T3 (es) 2016-03-01
EA200702039A1 (ru) 2008-02-28
NO20075385L (no) 2007-12-14
KR101323665B1 (ko) 2013-10-31
WO2006101603A1 (en) 2006-09-28
EP1861401A1 (en) 2007-12-05
ZA200708868B (en) 2009-01-28
IL186041A0 (en) 2008-02-09
MY147638A (en) 2012-12-31
EP1861401B1 (en) 2015-11-18

Similar Documents

Publication Publication Date Title
MY176860A (en) 7-amino alkylidenyl-heterocyclic quinolones and napthyridones
NO20075385L (no) 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner
UA94833C2 (en) Substituted bicyclolactams
HRP20120323T1 (en) Diarylhydantoin compounds
AU2006304874A8 (en) Pyrimidinones as casein kinase II (CK2) modulators
WO2008005368A3 (en) Piperazines as p2x7 antagonists
GEP20104943B (en) Fused heterocyclic compounds useful as kinase modulators
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
TNSN08191A1 (en) Kinase inhibitors
IL192033A0 (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
IN2014DN02014A (ru)
TW200728307A (en) Novel spirochromanone derivatives
TW200612958A (en) Substituted imidazole derivatives
GB0521508D0 (en) Organic compounds
WO2005094329A8 (en) Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
WO2008047951A3 (en) An alzheimer' s disease progression inhibitor containing heterocyclic compound
WO2004091504A3 (en) Substituted quinobenzoxazine analogs
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
MX2007004698A (es) Sintesis asimetrica de dihidrobenzofuranos sustituidos.
ITBO20060719A1 (it) Macchina per la produzione di filtri composti.
WO2010056633A3 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
MXPA05009523A (es) Derivados de quinolina/benzoxazinona y sus usos.
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
ITBO20060720A1 (it) Macchina per la produzione di filtri composti.